“Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study: Ceftolozane-Tazobatam for febrile neutropenia” (2020) Mediterranean Journal of Hematology and Infectious Diseases, 12(1), p. e2020065. doi:10.4084/mjhid.2020.065.